Zacks Premium
Overview
Zacks Premium provides access to the Zacks Rank — a proprietary quantitative stock rating system that ranks equities from #1 (Strong Buy) to #5 (Strong Sell) based primarily on earnings estimate revisions. The Zacks Rank has one of the longest published academic-style track records of any systematic stock selection methodology, with documented outperformance dating back to the 1980s. At $249/year, it's an affordable quantitative stock screening service from one of the most established names in quantitative equity research.
How It Works
The Zacks Rank system is based on a simple but powerful insight: stocks with upward-revising earnings estimates tend to outperform, while those with downward-revising estimates tend to underperform. The rank aggregates analyst earnings estimate changes, surprise factors, and estimate momentum into a single 1-5 rating.
Zacks Premium provides access to the full ranking database, filtered stock screeners, industry analysis, and portfolio recommendations. The stock screener lets subscribers filter by Zacks Rank, sector, market cap, and other criteria to build personalised watchlists.
The service also includes Zacks' analyst reports, research articles, and model portfolios that apply the ranking methodology to specific investment strategies (growth, value, income, etc.). The research depth positions Zacks as more than a signal service — it's a quantitative equity research platform.
The format is more screener/research than alert — subscribers use the ranking system to identify opportunities rather than receiving push notifications for specific trades.
Performance Analysis
The Zacks Rank methodology has one of the most documented performance histories in quantitative equity research. Academic-style backtesting shows that portfolios of Zacks #1 (Strong Buy) stocks have historically outperformed the S&P 500, while #5 (Strong Sell) stocks have historically underperformed — the earnings estimate revision thesis is well-supported by decades of data.
Our 3.0 verified performance score reflects the published methodology track record — genuinely rigorous by quantitative research standards, documented over decades, but self-published (by Zacks) rather than independently audited. The methodology is transparent enough that independent researchers have validated the earnings revision premium.
The practical subscriber question is whether the historical edge persists in real-time application. Factor premiums tend to shrink as they become widely known, and the Zacks Rank is one of the most widely cited quantitative factors in equity research. Some erosion of the historical edge is expected.
Strengths
- Zacks Rank earnings revision methodology has one of the longest documented track records in quantitative equity research
- Affordable at $249/year for a comprehensive quantitative stock screening platform
- Full database of ranked stocks with filtering tools for personalised screening
- Transparent methodology — the earnings estimate revision thesis is well-documented and independently validatable
- Research articles and model portfolios apply the ranking to multiple investment strategies
- Established brand with decades of institutional credibility in quantitative finance
Weaknesses
- Screener/research format rather than signal service — no structured trade alerts with entry/stop/target
- Factor premium (earnings revision) may have eroded as it became widely known and exploited
- Risk management is not addressed — no stop losses, position sizing, or portfolio risk framework
- Self-published performance rather than independently audited — despite methodological transparency
- Equities-only with no options, forex, futures, or crypto coverage
- Information overload — the full database and screening tools can overwhelm subscribers who want simple picks
Pricing & Value
At $249/year (~$21/month), Zacks Premium is among the cheapest quantitative equity research services available. For comparison: Motley Fool Stock Advisor costs $199/year for two picks per month. IBD Leaderboard costs $70/month for CAN SLIM stock selection. The Empirical Collective (#35) charges $50/month for factor-based research.
The Zacks Rank database and screening tools provide significantly more analytical depth than most services at this price point. The research platform alone — independent of signal value — is worth consideration for quantitatively-oriented investors.
How It Compares
Against IBD Leaderboard (#36), Zacks provides quantitative rankings (earnings revisions) while IBD provides CAN SLIM growth stock selection. Both are systematic; they target different types of stocks. Zacks is cheaper ($249/year vs $840/year) but provides less active trade management guidance.
Against Motley Fool Stock Advisor (#41), Zacks is more quantitative (systematic ranking) while Motley Fool is more qualitative (analyst picks). Zacks provides a screening tool; Motley Fool provides curated recommendations. Similar pricing with different approaches.
Against The Empirical Collective (#35), both are quant-oriented but Zacks has a far longer track record and focuses specifically on earnings revision momentum. TEC applies broader factor analysis. Zacks is cheaper and more established.
The honest positioning: Zacks Premium is one of the most cost-effective quantitative equity research subscriptions available, backed by decades of methodology documentation.
Who Is This For?
Quantitatively-oriented equity investors who want a systematic stock screening platform backed by decades of documented methodology. Best for self-directed investors who can translate Zacks Rank data into their own trade plans.
Not ideal for traders wanting structured buy/sell signals, options or forex traders, beginners overwhelmed by data-heavy platforms, or those requiring independent (non-Zacks) performance auditing.
Our Verdict
Zacks Premium earns #48 for providing one of the most cost-effective and longest-documented quantitative equity research platforms available. The Zacks Rank methodology's earnings revision thesis is well-supported by decades of evidence and transparent enough for independent validation.
The ranking reflects the research-not-signal nature of the product. Zacks provides the analytical framework and data; subscribers must supply their own trade execution, risk management, and timing. As a research platform, it's arguably underranked. As a signal service, it's missing the signal component.
For quantitative equity investors, Zacks Premium is exceptional value. For traders needing actionable signals, the services ranked above deliver more directly tradeable output.